 | • レポートコード：QY2108PAL8842 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、156ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける止血剤の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、止血剤の種類別市場規模（ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他）、用途別市場規模（病院、外科センター、老人ホーム）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の止血剤市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における止血剤の種類別市場規模（2016年-2027年）：ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他 ・世界における止血剤の用途別市場規模（2016年-2027年）：病院、外科センター、老人ホーム ・止血剤の中国市場分析 - 止血剤の中国市場規模（2016年-2027年） - 中国における止血剤の主要プレイヤー別市場シェア - 中国における止血剤の種類別市場規模：ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他 - 中国における止血剤の用途別市場規模：病院、外科センター、老人ホーム ・止血剤の北米市場（2016年-2027年） ・止血剤のヨーロッパ市場（2016年-2027年） ・止血剤のアジア太平洋市場（2016年-2027年） ・止血剤の中南米市場（2016年-2027年） ・止血剤の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Ethicon、Pfizer、Baxter International、C. R. Bard、The Medicines Company、Anika Therapeutics、Advanced Medical Solutions、Integra LifeSciences、B Braun Melsungen、Gelita Medical、Equimedical、Vascular Solutions、Marine Polymer Technologies、Z-Medica、CryoLife、BioCer Entwicklungs、Biom’Up SAS ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
The world’s leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.
Market Analysis and Insights: Global and China Hemostatic Agents Market
This report focuses on global and China Hemostatic Agents market.
In 2020, the global Hemostatic Agents market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Hemostatic Agents market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Hemostatic Agents Scope and Market Size
Hemostatic Agents market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Hemostatic Agents market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
1 Study Coverage
1.1 Hemostatic Agents Product Introduction
1.2 Market by Type
1.2.1 Global Hemostatic Agents Market Size Growth Rate by Type
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hemostatic Agents Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemostatic Agents Market Size, Estimates and Forecasts
2.1.1 Global Hemostatic Agents Revenue 2016-2027
2.1.2 Global Hemostatic Agents Sales 2016-2027
2.2 Global Hemostatic Agents, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hemostatic Agents Historical Market Size by Region (2016-2021)
2.3.1 Global Hemostatic Agents Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hemostatic Agents Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hemostatic Agents Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hemostatic Agents Sales Forecast by Region (2022-2027)
2.4.2 Global Hemostatic Agents Revenue Forecast by Region (2022-2027)
3 Global Hemostatic Agents Competitor Landscape by Players
3.1 Global Top Hemostatic Agents Manufacturers by Sales
3.1.1 Global Hemostatic Agents Sales by Manufacturer (2016-2021)
3.1.2 Global Hemostatic Agents Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hemostatic Agents Manufacturers by Revenue
3.2.1 Key Hemostatic Agents Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hemostatic Agents Revenue by Manufacturers (2016-2021)
3.2.3 Global Hemostatic Agents Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hemostatic Agents Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hemostatic Agents Revenue in 2020
3.2.6 Global Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hemostatic Agents Price by Manufacturers
3.4 Global Hemostatic Agents Manufacturing Base Distribution, Product Types
3.4.1 Hemostatic Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemostatic Agents Product Type
3.4.3 Date of International Manufacturers Enter into Hemostatic Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Hemostatic Agents Market Size by Type (2016-2021)
4.1.1 Global Hemostatic Agents Sales by Type (2016-2021)
4.1.2 Global Hemostatic Agents Revenue by Type (2016-2021)
4.1.3 Hemostatic Agents Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hemostatic Agents Market Size Forecast by Type (2022-2027)
4.2.1 Global Hemostatic Agents Sales Forecast by Type (2022-2027)
4.2.2 Global Hemostatic Agents Revenue Forecast by Type (2022-2027)
4.2.3 Hemostatic Agents Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Hemostatic Agents Market Size by Application (2016-2021)
5.1.1 Global Hemostatic Agents Sales by Application (2016-2021)
5.1.2 Global Hemostatic Agents Revenue by Application (2016-2021)
5.1.3 Hemostatic Agents Price by Application (2016-2021)
5.2 Hemostatic Agents Market Size Forecast by Application (2022-2027)
5.2.1 Global Hemostatic Agents Sales Forecast by Application (2022-2027)
5.2.2 Global Hemostatic Agents Revenue Forecast by Application (2022-2027)
5.2.3 Global Hemostatic Agents Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Hemostatic Agents Market Size YoY Growth 2016-2027
6.1.1 China Hemostatic Agents Sales YoY Growth 2016-2027
6.1.2 China Hemostatic Agents Revenue YoY Growth 2016-2027
6.1.3 China Hemostatic Agents Market Share in Global Market 2016-2027
6.2 China Hemostatic Agents Market Size by Players (International and Local Players)
6.2.1 China Top Hemostatic Agents Players by Sales (2016-2021)
6.2.2 China Top Hemostatic Agents Players by Revenue (2016-2021)
6.3 China Hemostatic Agents Historic Market Review by Type (2016-2021)
6.3.1 China Hemostatic Agents Sales Market Share by Type (2016-2021)
6.3.2 China Hemostatic Agents Revenue Market Share by Type (2016-2021)
6.3.3 China Hemostatic Agents Price by Type (2016-2021)
6.4 China Hemostatic Agents Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Hemostatic Agents Sales Forecast by Type (2022-2027)
6.4.2 China Hemostatic Agents Revenue Forecast by Type (2022-2027)
6.4.3 China Hemostatic Agents Price Forecast by Type (2022-2027)
6.5 China Hemostatic Agents Historic Market Review by Application (2016-2021)
6.5.1 China Hemostatic Agents Sales Market Share by Application (2016-2021)
6.5.2 China Hemostatic Agents Revenue Market Share by Application (2016-2021)
6.5.3 China Hemostatic Agents Price by Application (2016-2021)
6.6 China Hemostatic Agents Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Hemostatic Agents Sales Forecast by Application (2022-2027)
6.6.2 China Hemostatic Agents Revenue Forecast by Application (2022-2027)
6.6.3 China Hemostatic Agents Price Forecast by Application (2022-2027)
7 North America
7.1 North America Hemostatic Agents Market Size YoY Growth 2016-2027
7.2 North America Hemostatic Agents Market Facts & Figures by Country
7.2.1 North America Hemostatic Agents Sales by Country (2016-2021)
7.2.2 North America Hemostatic Agents Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Hemostatic Agents Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hemostatic Agents Market Facts & Figures by Region
8.2.1 Asia Pacific Hemostatic Agents Sales by Region (2016-2021)
8.2.2 Asia Pacific Hemostatic Agents Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Hemostatic Agents Market Size YoY Growth 2016-2027
9.2 Europe Hemostatic Agents Market Facts & Figures by Country
9.2.1 Europe Hemostatic Agents Sales by Country (2016-2021)
9.2.2 Europe Hemostatic Agents Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Hemostatic Agents Market Size YoY Growth 2016-2027
10.2 Latin America Hemostatic Agents Market Facts & Figures by Country
10.2.1 Latin America Hemostatic Agents Sales by Country (2016-2021)
10.2.2 Latin America Hemostatic Agents Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hemostatic Agents Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hemostatic Agents Market Facts & Figures by Country
11.2.1 Middle East and Africa Hemostatic Agents Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hemostatic Agents Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Ethicon
12.1.1 Ethicon Corporation Information
12.1.2 Ethicon Description and Business Overview
12.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Ethicon Hemostatic Agents Products Offered
12.1.5 Ethicon Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Hemostatic Agents Products Offered
12.2.5 Pfizer Recent Development
12.3 Baxter International
12.3.1 Baxter International Corporation Information
12.3.2 Baxter International Description and Business Overview
12.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Baxter International Hemostatic Agents Products Offered
12.3.5 Baxter International Recent Development
12.4 C. R. Bard
12.4.1 C. R. Bard Corporation Information
12.4.2 C. R. Bard Description and Business Overview
12.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.4.4 C. R. Bard Hemostatic Agents Products Offered
12.4.5 C. R. Bard Recent Development
12.5 The Medicines Company
12.5.1 The Medicines Company Corporation Information
12.5.2 The Medicines Company Description and Business Overview
12.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.5.4 The Medicines Company Hemostatic Agents Products Offered
12.5.5 The Medicines Company Recent Development
12.6 Anika Therapeutics
12.6.1 Anika Therapeutics Corporation Information
12.6.2 Anika Therapeutics Description and Business Overview
12.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Anika Therapeutics Hemostatic Agents Products Offered
12.6.5 Anika Therapeutics Recent Development
12.7 Advanced Medical Solutions
12.7.1 Advanced Medical Solutions Corporation Information
12.7.2 Advanced Medical Solutions Description and Business Overview
12.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Advanced Medical Solutions Hemostatic Agents Products Offered
12.7.5 Advanced Medical Solutions Recent Development
12.8 Integra LifeSciences
12.8.1 Integra LifeSciences Corporation Information
12.8.2 Integra LifeSciences Description and Business Overview
12.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Integra LifeSciences Hemostatic Agents Products Offered
12.8.5 Integra LifeSciences Recent Development
12.9 B Braun Melsungen
12.9.1 B Braun Melsungen Corporation Information
12.9.2 B Braun Melsungen Description and Business Overview
12.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.9.4 B Braun Melsungen Hemostatic Agents Products Offered
12.9.5 B Braun Melsungen Recent Development
12.10 Gelita Medical
12.10.1 Gelita Medical Corporation Information
12.10.2 Gelita Medical Description and Business Overview
12.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Gelita Medical Hemostatic Agents Products Offered
12.10.5 Gelita Medical Recent Development
12.11 Ethicon
12.11.1 Ethicon Corporation Information
12.11.2 Ethicon Description and Business Overview
12.11.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Ethicon Hemostatic Agents Products Offered
12.11.5 Ethicon Recent Development
12.12 Vascular Solutions
12.12.1 Vascular Solutions Corporation Information
12.12.2 Vascular Solutions Description and Business Overview
12.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Vascular Solutions Products Offered
12.12.5 Vascular Solutions Recent Development
12.13 Marine Polymer Technologies
12.13.1 Marine Polymer Technologies Corporation Information
12.13.2 Marine Polymer Technologies Description and Business Overview
12.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Marine Polymer Technologies Products Offered
12.13.5 Marine Polymer Technologies Recent Development
12.14 Z-Medica
12.14.1 Z-Medica Corporation Information
12.14.2 Z-Medica Description and Business Overview
12.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Z-Medica Products Offered
12.14.5 Z-Medica Recent Development
12.15 CryoLife
12.15.1 CryoLife Corporation Information
12.15.2 CryoLife Description and Business Overview
12.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.15.4 CryoLife Products Offered
12.15.5 CryoLife Recent Development
12.16 BioCer Entwicklungs
12.16.1 BioCer Entwicklungs Corporation Information
12.16.2 BioCer Entwicklungs Description and Business Overview
12.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.16.4 BioCer Entwicklungs Products Offered
12.16.5 BioCer Entwicklungs Recent Development
12.17 Biom’Up SAS
12.17.1 Biom’Up SAS Corporation Information
12.17.2 Biom’Up SAS Description and Business Overview
12.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Biom’Up SAS Products Offered
12.17.5 Biom’Up SAS Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hemostatic Agents Industry Trends
13.2 Hemostatic Agents Market Drivers
13.3 Hemostatic Agents Market Challenges
13.4 Hemostatic Agents Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemostatic Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Hemostatic Agents Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Gelation Sponge
Table 3. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats
Table 4. Major Manufacturers of Others
Table 5. Global Hemostatic Agents Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Hemostatic Agents Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Hemostatic Agents Sales by Regions (2016-2021) & (K Units)
Table 8. Global Hemostatic Agents Sales Market Share by Regions (2016-2021)
Table 9. Global Hemostatic Agents Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Hemostatic Agents Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Hemostatic Agents Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Hemostatic Agents Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Hemostatic Agents Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Hemostatic Agents Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Hemostatic Agents Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Hemostatic Agents Manufacturers by Revenue (US$ Million) in 2020
Table 17. Hemostatic Agents Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Hemostatic Agents Revenue Share by Manufacturers (2016-2021)
Table 19. Global Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Hemostatic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostatic Agents as of 2020)
Table 21. Key Manufacturers Hemostatic Agents Price (2016-2021) (USD/Unit)
Table 22. Hemostatic Agents Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Hemostatic Agents Product Type
Table 24. Date of International Manufacturers Enter into Hemostatic Agents Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Hemostatic Agents Sales by Type (2016-2021) (K Units)
Table 27. Global Hemostatic Agents Sales Share by Type (2016-2021)
Table 28. Global Hemostatic Agents Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Hemostatic Agents Revenue Share by Type (2016-2021)
Table 30. Hemostatic Agents Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Hemostatic Agents Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Hemostatic Agents Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Hemostatic Agents Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Hemostatic Agents Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Hemostatic Agents Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Hemostatic Agents Sales by Application (2016-2021) (K Units)
Table 37. Global Hemostatic Agents Sales Share by Application (2016-2021)
Table 38. Global Hemostatic Agents Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Hemostatic Agents Revenue Share by Application (2016-2021)
Table 40. Hemostatic Agents Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Hemostatic Agents Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Hemostatic Agents Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Hemostatic Agents Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Hemostatic Agents Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Hemostatic Agents Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. China Hemostatic Agents Sales (K Units) of Key Companies (2016-2021)
Table 47. China Hemostatic Agents Sales Share by Company (2016-2021)
Table 48. China Hemostatic Agents Revenue (US$ Million) by Company (2016-2021)
Table 49. China Hemostatic Agents Revenue Share by Company (2016-2021)
Table 50. China Hemostatic Agents Sales (K Units) by Type (2016-2021)
Table 51. China Hemostatic Agents Sales Share by Type (2016-2021)
Table 52. China Hemostatic Agents Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Hemostatic Agents Price (USD/Unit) by Type (2016-2021)
Table 54. China Hemostatic Agents Sales (K Units) by Type (2022-2027)
Table 55. China Hemostatic Agents Sales Share by Type (2022-2027)
Table 56. China Hemostatic Agents Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Hemostatic Agents Revenue Share by Type (2022-2027)
Table 58. China Hemostatic Agents Price (USD/Unit) by Type (2022-2027)
Table 59. China Hemostatic Agents Sales (K Units) by Application (2016-2021)
Table 60. China Hemostatic Agents Sales Share by Application (2016-2021)
Table 61. China Hemostatic Agents Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Hemostatic Agents Price (USD/Unit) by Application (2016-2021)
Table 63. China Hemostatic Agents Sales (K Units) by Application (2022-2027)
Table 64. China Hemostatic Agents Sales Share by Application (2022-2027)
Table 65. China Hemostatic Agents Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Hemostatic Agents Revenue Share by Application (2022-2027)
Table 67. China Hemostatic Agents Price (USD/Unit) by Application (2022-2027)
Table 68. North America Hemostatic Agents Sales by Country (2016-2021) & (K Units)
Table 69. North America Hemostatic Agents Sales Market Share by Country (2016-2021)
Table 70. North America Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Hemostatic Agents Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Hemostatic Agents Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Hemostatic Agents Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Hemostatic Agents Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Hemostatic Agents Revenue Market Share by Region (2016-2021)
Table 76. Europe Hemostatic Agents Sales by Country (2016-2021) & (K Units)
Table 77. Europe Hemostatic Agents Sales Market Share by Country (2016-2021)
Table 78. Europe Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Hemostatic Agents Revenue Market Share by Country (2016-2021)
Table 80. Latin America Hemostatic Agents Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Hemostatic Agents Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Hemostatic Agents Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Hemostatic Agents Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Hemostatic Agents Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Hemostatic Agents Revenue Market Share by Country (2016-2021)
Table 88. Ethicon Corporation Information
Table 89. Ethicon Description and Business Overview
Table 90. Ethicon Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Ethicon Hemostatic Agents Product
Table 92. Ethicon Recent Development
Table 93. Pfizer Corporation Information
Table 94. Pfizer Description and Business Overview
Table 95. Pfizer Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Pfizer Product
Table 97. Pfizer Recent Development
Table 98. Baxter International Corporation Information
Table 99. Baxter International Description and Business Overview
Table 100. Baxter International Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Baxter International Product
Table 102. Baxter International Recent Development
Table 103. C. R. Bard Corporation Information
Table 104. C. R. Bard Description and Business Overview
Table 105. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. C. R. Bard Product
Table 107. C. R. Bard Recent Development
Table 108. The Medicines Company Corporation Information
Table 109. The Medicines Company Description and Business Overview
Table 110. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. The Medicines Company Product
Table 112. The Medicines Company Recent Development
Table 113. Anika Therapeutics Corporation Information
Table 114. Anika Therapeutics Description and Business Overview
Table 115. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Anika Therapeutics Product
Table 117. Anika Therapeutics Recent Development
Table 118. Advanced Medical Solutions Corporation Information
Table 119. Advanced Medical Solutions Description and Business Overview
Table 120. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Advanced Medical Solutions Product
Table 122. Advanced Medical Solutions Recent Development
Table 123. Integra LifeSciences Corporation Information
Table 124. Integra LifeSciences Description and Business Overview
Table 125. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Integra LifeSciences Product
Table 127. Integra LifeSciences Recent Development
Table 128. B Braun Melsungen Corporation Information
Table 129. B Braun Melsungen Description and Business Overview
Table 130. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. B Braun Melsungen Product
Table 132. B Braun Melsungen Recent Development
Table 133. Gelita Medical Corporation Information
Table 134. Gelita Medical Description and Business Overview
Table 135. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Gelita Medical Product
Table 137. Gelita Medical Recent Development
Table 138. Equimedical Corporation Information
Table 139. Equimedical Description and Business Overview
Table 140. Equimedical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Equimedical Product
Table 142. Equimedical Recent Development
Table 143. Vascular Solutions Corporation Information
Table 144. Vascular Solutions Description and Business Overview
Table 145. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Vascular Solutions Product
Table 147. Vascular Solutions Recent Development
Table 148. Marine Polymer Technologies Corporation Information
Table 149. Marine Polymer Technologies Description and Business Overview
Table 150. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Marine Polymer Technologies Product
Table 152. Marine Polymer Technologies Recent Development
Table 153. Z-Medica Corporation Information
Table 154. Z-Medica Description and Business Overview
Table 155. Z-Medica Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. Z-Medica Product
Table 157. Z-Medica Recent Development
Table 158. CryoLife Corporation Information
Table 159. CryoLife Description and Business Overview
Table 160. CryoLife Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 161. CryoLife Product
Table 162. CryoLife Recent Development
Table 163. BioCer Entwicklungs Corporation Information
Table 164. BioCer Entwicklungs Description and Business Overview
Table 165. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 166. BioCer Entwicklungs Product
Table 167. BioCer Entwicklungs Recent Development
Table 168. Biom’Up SAS Corporation Information
Table 169. Biom’Up SAS Description and Business Overview
Table 170. Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 171. Biom’Up SAS Product
Table 172. Biom’Up SAS Recent Development
Table 173. Hemostatic Agents Market Trends
Table 174. Hemostatic Agents Market Drivers
Table 175. Hemostatic Agents Market Challenges
Table 176. Hemostatic Agents Market Restraints
Table 177. Hemostatic Agents Customers List
Table 178. Hemostatic Agents Distributors List
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic Agents Product Picture
Figure 2. Global Hemostatic Agents Sales Market Share by Type in 2020 & 2027
Figure 3. Gelation Sponge Product Picture
Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 5. Others Product Picture
Figure 6. Global Hemostatic Agents Sales Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Surgical Centers
Figure 9. Nursing Homes
Figure 10. Hemostatic Agents Report Years Considered
Figure 11. Global Hemostatic Agents Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hemostatic Agents Market Size 2016-2027 (US$ Million)
Figure 13. Global Hemostatic Agents Sales 2016-2027 (K Units)
Figure 14. Global Hemostatic Agents Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Hemostatic Agents Sales Market Share by Region (2016-2021)
Figure 16. Global Hemostatic Agents Sales Market Share by Region in 2020
Figure 17. Global Hemostatic Agents Revenue Market Share by Region (2016-2021)
Figure 18. Global Hemostatic Agents Revenue Market Share by Region in 2020
Figure 19. Global Hemostatic Agents Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Hemostatic Agents Revenue in 2020
Figure 21. Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Hemostatic Agents Sales Market Share by Type (2016-2021)
Figure 23. Global Hemostatic Agents Sales Market Share by Type in 2020
Figure 24. Global Hemostatic Agents Revenue Market Share by Type (2016-2021)
Figure 25. Global Hemostatic Agents Revenue Market Share by Type in 2020
Figure 26. Global Hemostatic Agents Sales Market Share by Application (2016-2021)
Figure 27. Global Hemostatic Agents Sales Market Share by Application in 2020
Figure 28. Global Hemostatic Agents Revenue Market Share by Application (2016-2021)
Figure 29. Global Hemostatic Agents Revenue Market Share by Application in 2020
Figure 30. China Hemostatic Agents Sales Growth Rate 2016-2027 (K Units)
Figure 31. China Hemostatic Agents Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Hemostatic Agents Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Hemostatic Agents Players Market Share by Revenue in Hemostatic Agents in 2020
Figure 34. China Hemostatic Agents Revenue Share by Type (2016-2021)
Figure 35. China Hemostatic Agents Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Hemostatic Agents Revenue Share by Application (2016-2021)
Figure 37. China Hemostatic Agents Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Hemostatic Agents Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Hemostatic Agents Sales Market Share by Country in 2020
Figure 41. North America Hemostatic Agents Revenue Market Share by Country in 2020
Figure 42. U.S. Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 43. U.S. Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Hemostatic Agents Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Hemostatic Agents Sales Market Share by Country in 2020
Figure 49. Europe Hemostatic Agents Revenue Market Share by Country in 2020
Figure 50. Germany Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Hemostatic Agents Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Hemostatic Agents Sales Market Share by Region in 2020
Figure 63. Asia Pacific Hemostatic Agents Revenue Market Share by Region in 2020
Figure 64. China Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 65. China Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 67. Japan Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 69. South Korea Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 71. India Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 73. Australia Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 75. Taiwan Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 77. Indonesia Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 79. Thailand Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 81. Malaysia Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 83. Philippines Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 85. Vietnam Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Hemostatic Agents Sales Growth Rate 2016-2021 (K Units)
Figure 87. Latin America Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Hemostatic Agents Sales Market Share by Country in 2020
Figure 89. Latin America Hemostatic Agents Revenue Market Share by Country in 2020
Figure 90. Mexico Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 91. Mexico Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 93. Brazil Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 95. Argentina Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Hemostatic Agents Sales Growth Rate 2016-2021 (K Units)
Figure 97. Middle East and Africa Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Hemostatic Agents Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Hemostatic Agents Revenue Market Share by Country in 2020
Figure 100. Turkey Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 101. Turkey Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 103. Saudi Arabia Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. U.A.E Hemostatic Agents Sales Growth Rate (2016-2021) (K Units)
Figure 105. U.A.E Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Hemostatic Agents Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
止血剤・組織封止剤の世界及び中国市場 Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of…- 止血ジェルの世界及び中国市場 Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.…
- 世界の止血パウダー市場インサイト・予測（～2027年） Market Analysis and Insights: Global Hemostatic Powder Market The global Hemostatic Powder market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Hemostatic Powder Scope and Segment Hemostatic Powder…
- 止血鉗子の世界市場 2020年 Market Overview The Hemostatic Forceps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 止血アナライザーの世界市場 2020年 Market Overview The global Hemostatic Analyzer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hemostatic Analyzer marke…